Reducing the risk of transfusion transmitted Hepatitis B in New Zealand
Flanagan P, Charlewood RG, Horder S, et al.: Reducing the risk of transfusion transmitted Hepatitis B in New Zealand. Vox Sang 2005; 89(suppl 2):23-24.
HBV Yield Using a 2nd generation Procleix Ultrio assay in a non-HBV core screened population
Margaritis A, Lin CK, Ismay S, et al.: HBV Yield Using a 2nd generation Procleix Ultrio assay in a non-HBV core screened population. Transfusion 2008; 48(suppl 2):110A.
Hepatitis B virus transmission by blood transfusion during 4years of individual-donation nucleic acid testing in South Africa: estimated and observed window period risk. Transfusion
Vermeulen M, Dickens C, Lelie N, et al.: Hepatitis B virus transmission by blood transfusion during 4years of individual-donation nucleic acid testing in South Africa: estimated and observed window period risk. Transfusion 2011; 52:880-892.
Frequent presence of HBV in the sera of HBsAg-negative, anti-HBc-positive blood donors
Yotsuyanagi H, Yasuda K, Moriya K, et al.: Frequent presence of HBV in the sera of HBsAg-negative, anti-HBc-positive blood donors. Transfusion 2001; 41:1093-1099.
Quantification of hepatitis B virus genomes and infectivity in human serum samples
Hsia CC, Purcell RH, Farshid M et al.: Quantification of hepatitis B virus genomes and infectivity in human serum samples. Transfusion 2006; 46:1829-1835.